Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice
Authors
Keywords
-
Journal
JCO Oncology Practice
Volume 17, Issue 12, Pages 697-706
Publisher
American Society of Clinical Oncology (ASCO)
Online
2021-10-16
DOI
10.1200/op.21.00635
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial
- (2021) Roberto Orecchia et al. LANCET ONCOLOGY
- Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases
- (2021) Steve Chmura et al. JAMA Oncology
- Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline
- (2021) Muriel Brackstone et al. JOURNAL OF CLINICAL ONCOLOGY
- Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer
- (2020) Wendy A. Woodward et al. JAMA Oncology
- Validation of a ductal carcinoma in situ biomarker profile for risk of recurrence after breast-conserving surgery with and without radiation therapy
- (2020) Sheila Weinmann et al. CLINICAL CANCER RESEARCH
- Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
- (2020) Adrian Murray Brunt et al. LANCET
- Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival
- (2020) Jayant S. Vaidya et al. JAMA Oncology
- Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer
- (2020) Adrian Murray Brunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
- (2020) David A. Palma et al. JOURNAL OF CLINICAL ONCOLOGY
- Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial
- (2020) Icro Meattini et al. JOURNAL OF CLINICAL ONCOLOGY
- Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial
- (2020) Jayant S Vaidya et al. BMJ-British Medical Journal
- Efficacy, Improved Quality of Life, and Cost-effectiveness of Partial Breast Irradiation
- (2020) Chirag Shah et al. JAMA Oncology
- Breast-Conserving Surgery Followed by Partial or Whole Breast Irradiation: Twenty-Year Results of a Phase 3 Clinical Study
- (2020) Csaba Polgár et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Three-Fraction Accelerated Partial Breast Irradiation (Apbi) Delivered With Brachytherapy Applicators Is Feasible And Safe : First Results From The Triumph-T Trial
- (2019) Atif J. Khan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial
- (2019) Shu-Lian Wang et al. LANCET ONCOLOGY
- Radiation Therapy Without Hormone Therapy for Women Age 70 or Above with Low-Risk Early Breast Cancer: A Microsimulation
- (2019) Matthew C. Ward et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor–Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database
- (2019) Samantha M. Buszek et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer
- (2019) Martin Sjöström et al. JOURNAL OF CLINICAL ONCOLOGY
- External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial
- (2019) Timothy J Whelan et al. LANCET
- Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial
- (2019) Frank A Vicini et al. LANCET
- The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation
- (2018) Chirag Shah et al. Brachytherapy
- Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials
- (2018) Joanne S Haviland et al. RADIOTHERAPY AND ONCOLOGY
- Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
- (2018) Viviana Galimberti et al. LANCET ONCOLOGY
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
- (2017) Armando E. Giuliano et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial
- (2017) Atif J. Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
- (2017) Charlotte E Coles et al. LANCET
- Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial
- (2017) Csaba Polgár et al. LANCET ONCOLOGY
- Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial.
- (2017) T. B. Julian et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Update of NRG Oncology RTOG 0319: A Phase 1 and 2 Trial to Evaluate 3-Dimensional Conformal Radiation Therapy Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma
- (2016) Rachel Rabinovitch et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
- (2016) Abram Recht et al. JOURNAL OF CLINICAL ONCOLOGY
- 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial
- (2016) Vratislav Strnad et al. LANCET
- Intraoperative breast radiation therapy with image guidance: Findings from CT images obtained in a prospective trial of intraoperative high-dose-rate brachytherapy with CT on rails
- (2015) Daniel M. Trifiletti et al. Brachytherapy
- Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy
- (2015) Fei-Fei Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
- (2015) Ian H Kunkler et al. LANCET ONCOLOGY
- Regional Nodal Irradiation in Early-Stage Breast Cancer
- (2015) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation
- (2015) Simona F. Shaitelman et al. JAMA Oncology
- Decline of Cosmetic Outcomes Following Accelerated Partial Breast Irradiation Using Intensity Modulated Radiation Therapy: Results of a Single-Institution Prospective Clinical Trial
- (2014) Adam L. Liss et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial
- (2014) Reshma Jagsi et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
- (2014) EBCTCG (Early Breast Cancer Trialists' Collaborative Group) LANCET
- Radiotherapy for breast cancer, the TARGIT-A trial
- (2014) Jack Cuzick LANCET
- Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy
- (2014) Chirag Shah et al. RADIOTHERAPY AND ONCOLOGY
- Treatment Efficacy with Accelerated Partial Breast Irradiation (APBI): Final Analysis of the American Society of Breast Surgeons MammoSite® Breast Brachytherapy Registry Trial
- (2013) Chirag Shah et al. ANNALS OF SURGICAL ONCOLOGY
- Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis
- (2013) Chirag Shah et al. Brachytherapy
- Five-Year Outcomes, Cosmesis, and Toxicity With 3-Dimensional Conformal External Beam Radiation Therapy to Deliver Accelerated Partial Breast Irradiation
- (2013) Núria Rodríguez et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
- (2013) Kevin S. Hughes et al. JOURNAL OF CLINICAL ONCOLOGY
- A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
- (2013) L. J. Solin et al. JNCI-Journal of the National Cancer Institute
- Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial
- (2013) Jayant S Vaidya et al. LANCET
- The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
- (2013) Joanne S Haviland et al. LANCET ONCOLOGY
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
- (2013) Sarah C. Darby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Five-Year Outcomes and Toxicities Using 3-Dimensional Conformal External Beam Radiation Therapy to Deliver Accelerated Partial Breast Irradiation
- (2012) Chirag Shah et al. Clinical Breast Cancer
- Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
- (2012) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial
- (2012) Saskia Litière et al. LANCET ONCOLOGY
- Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
- (2010) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toxicity of Three-Dimensional Conformal Radiotherapy for Accelerated Partial Breast Irradiation
- (2009) Jaroslaw T. Hepel et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now